Cigna
Elizabeth Shanley, PA
Be the first to review this provider!
Albuquerque, NM
Accepting new patients
38 years of experience
Clinical Overview
Elizabeth Shanley, PA works in Albuquerque, NM as
Elizabeth Shanley graduated from Duke University School of Medicine in 1988. Elizabeth Shanley completed a residency at Montefiore Medical Center. Elizabeth Shanley is accepting new patients.
Elizabeth Shanley accepts many private insurances, Medicaid, and Medicare.
Insurance & Payment Information
* Please verify this information when scheduling an appointment.
-
-
First Health (Coventry Health Care)
-
GEHA
-
Medicaid
-
Molina
-
Lovelace Health Plan
-
Blue Cross Blue Shield of New Mexico
-
Aetna
-
Blue Cross and Blue Shield
-
HealthSmart
-
United Healthcare
-
Tricare
-
Presbyterian Health Plan, Inc.
-
MultiPlan PPO
-
Curative EPOCurative PPO PlusCurative PPO
-
Fortified Provider Network
-
Humana
-
Beech Street (Multiplan)
-
Medicare
-
Coventry Health Care
-
National (BlueCard) PPO
Office Locations
-
Hematology-Oncology Associates P C1001 Coal Ave SE, Albuquerque, NM 87106
-
Womens Specialists of N. Mex. LTD.6320 Riverside Plaza Ln NW Ste B, Albuquerque, NM 87120
Patient Experience & Satisfaction
Be the first to leave a review
How likely are you to recommend Elizabeth Shanley?
Step 1 of 3
Your review of Elizabeth Shanley, PA
50 characters remaining
1000 characters remaining
Was this a Telehealth appointment?
(This will display with your review)
Your email is used to confirm your review and will NOT appear in the review.
This name will appear with your review. If left blank, we'll use "Anonymous".
RVO Health property, Medical News Today, is owned by RVO Health. Please review our terms of use for more.
Help other patients find the right care by sharing a few more details about your visit.
Last step! Confirm your email.
We've sent an email to
Once you confirm, you can close this window.
Thank you for your review!
Your review has been confirmed and will be published after verification.
Thank you for your review!
We've sent a confirmation email. Your review will appear after you confirm it.
Please allow up to 30 seconds for the email to arrive. Don't see it? Make sure to check your 'spam' and 'updates' folder. Once you've confirmed your review, you can close this window.
Medical Expertise & Background
Specialties*
Geriatric Medicine
Gynecology
- *Medical News Today does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Common Patient Questions
Elizabeth Shanley, PA accepts new patients on Medical News Today.
Elizabeth Shanley accepts Medicare, Medicaid, Cigna, First Health, Government Employees Health Association (GEHA), Molina Healthcare, Lovelace Health Plan, Blue Cross and Blue Shield of New Mexico, Aetna, Blue Cross Blue Shield, HealthSmart, UnitedHealthCare, Tricare, Presbyterian Health Plan, MultiPlan, Curative, Fortified Provider Network, Humana, Beech Street (Multiplan), Coventry Health Care and Anthem as well as many others.
Elizabeth Shanley's office is located at 1001 Coal Ave SE Albuquerque, NM 87106. Get a map and directions to Elizabeth Shanley's office here.
Elizabeth Shanley does not have any reviews yet.
Elizabeth Shanley has been practicing as a Gynecology Specialist for 38 years.
Education & Credentials
Medical Education
-
Duke University School of Medicine
1988
Residency Hospital
-
Montefiore Medical Center
1997
Claim Your Profile
Are you Elizabeth Shanley, PA?
Know Before You Go
Preventive care: what doctors want you to know
Preventive care can help identify current or future health and medical concerns before they become major.
Featured Stories
The FDA has approved Moderna's new mRNA flu vaccine for adults ages 50 years and older. Moderna expects the vaccine to be available in the United States for the 2026 to 2027 flu season.
A natural compound derived from plant foods containing a certain type of polyphenol may help improve heart function in people with heart failure, a study in animals and human tissue models has found.
Moderna and Merck's neoantigen treatment, combining a personalized mRNA cancer vaccine with the immunotherapy drug pembrolizumab significantly reduced the risk of melanoma recurrence in a phase 3 trial.
